Skip to main content
OpenTrials

Clinical trial condition

Primary Peritoneal Carcinoma

Explore clinical trials studying Primary Peritoneal Carcinoma. Study availability and eligibility vary by location and protocol.

102 public trials 17 recruiting studies
Refine in advanced search Browse all conditions

Primary Peritoneal Carcinoma trial results

Recruiting

A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 Cycles of Platinum-based Chemotherapy in completeLy debUlked Advanced HRDpositive High-grade Ovarian Cancer patientS in First Line Therapy

NCT05460000

Conditions
Adenocarcinoma, Adenocarcinoma, Clear Cell, Adnexal Diseases, +23 more
Locations
  • Universitätsklinik Innsbruck Innsbruck, Austria
  • Cliniques Universitaires St. Luc Brussels, Belgium
  • UZ Gent Ghent, Belgium
  • Jessa ziekenhuis Hasselt, Belgium
View all 50 locations
View Trial Details
Recruiting

Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer

NCT06915025

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +22 more
Locations
  • Advent Health Orlando, Florida, United States
  • Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States
  • Washington University School of Medicine in St. Louis St Louis, Missouri, United States
  • Providence Cancer Institute Portland, Oregon, United States
View Trial Details
Recruiting

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

NCT05579366

Conditions
Adenoma, Adnexal Diseases, Breast Adenocarcinoma, +49 more
Locations
  • USOR HonorHealth Phoenix, Arizona, United States
  • USOR Arizona Oncology Associates Tucson, Arizona, United States
  • University of California Los Angeles Medical Center Los Angeles, California, United States
  • University of California, San Diego; Moores Cancer Center San Diego, California, United States
View all 66 locations
View Trial Details
Recruiting

A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)

NCT05429970

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +32 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activities) Commack, New York, United States
View Trial Details
Recruiting

A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers

NCT06469281

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • John Theurer Cancer Center Hackensack University Medical Center Hackensack, New Jersey, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
View Trial Details

Related conditions